Detailed Information on Publication Record
2019
Ebstein's anomaly with significant dysplasia of the tricuspid valve presenting at 73 years of age. A case report
KOC, Lumír, Jiri ONDRASEK, Tomas ZATOCIL, Anna NECASOVA, Jindřich ŠPINAR et. al.Basic information
Original name
Ebstein's anomaly with significant dysplasia of the tricuspid valve presenting at 73 years of age. A case report
Authors
KOC, Lumír (203 Czech Republic, guarantor, belonging to the institution), Jiri ONDRASEK (203 Czech Republic), Tomas ZATOCIL (203 Czech Republic), Anna NECASOVA (203 Czech Republic) and Jindřich ŠPINAR (203 Czech Republic, belonging to the institution)
Edition
Cor et Vasa, AMSTERDAM, ELSEVIER SCIENCE BV, 2019, 0010-8650
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
30201 Cardiac and Cardiovascular systems
Country of publisher
Netherlands
Confidentiality degree
není předmětem státního či obchodního tajemství
References:
RIV identification code
RIV/00216224:14110/19:00112953
Organization unit
Faculty of Medicine
UT WoS
000472526800010
Keywords in English
Ebstein's anomaly; Tricuspid regurgitation; Tricuspid valve dysplasia; Tricuspid valve replacement
Tags
International impact, Reviewed
Změněno: 11/5/2020 11:07, Mgr. Tereza Miškechová
Abstract
V originále
Ebstein's anomaly (EA) is a rare congenital heart defect, characterized by an anomalous tricuspid valve displaced towards the apex of the right ventricle (RV); it is usually accompanied by regurgitation. While its severe forms with an extremely dilated functional RV and oppression of the left heart chambers result in the development of severe heart failure at a young age and, in some cases, even prenatally, patients with mild EA may live until old age with the condition unrecognized. We present the case of a patient with a milder form of EA and a contribution of dysplasia, with the disease undiagnosed until his eighties when he developed heart failure accompanied by significant tricuspid regurgitation. Tricuspid valve replacement with a bioprosthesis and atrial septal defect occlusion were followed by significant improvement of RV function and remission of the patient's problems.